reiterating our outlook for fiscal year 2021.
compname reports q4 earnings per share $1.14.
q4 revenue $293.2 million versus refinitiv ibes estimate of $237.3 million.
q4 revenue $3 million versus refinitiv ibes estimate of $3.6 billion.
for quarter, net income for u.s. is $1,051 million.
q4 revenue $251.5 million versus refinitiv ibes estimate of $250.9 million.
q4 shipments volume and revenue to smile direct club excluding special items were immaterial to q4.
qtrly clear aligner revenue growth of 17.5% from a consolidated case volume of over $1 billion.
q4 international invisalign asps were down 50 percent sequentially, to about $1,230 versus q3.
quarterly total reported asp of $1.87 billion versus $1,553 million.
qtrly total invoice shipment of about 190,000 cases, up 6.9%.
qtrly case volume growth of 18.5%.
q4 revenue rose 3.2% sequentially and 20.2 percent year-over-year.
qtrly non-gaap case volume grew 9.1 percent and 9.5 percent sequentially, respectively.
qtrly international healthcare claims cases were up 25% sequentially and 9.1% year over year.
compname reports worldwide medical internship utilization of 5.2 cases per doctor in q4.
